Susquehanna International Group, LLP Imara Inc. Transaction History

Susquehanna International Group, LLP

  • $560 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.99 - $1.87 $19,770 - $37,343
-19,970 Reduced 16.9%
98,209 $120,000
Q1 2022

May 16, 2022
BUY
$1.15 - $2.41 $93,595 - $196,142
81,387 Added 221.21%
118,179 $222,000
Q4 2021

Feb 14, 2022
BUY
$2.25 - $4.05 $57,246 - $103,044
25,443 Added 224.19%
36,792 $83,000
Q3 2021

Nov 15, 2021
BUY
$4.08 - $7.83 $46,303 - $88,862
11,349 New
11,349 $46,000

Others Institutions Holding IMRA

# of Institutions
3
Shares Held
104K
Call Options Held
0
Put Options Held
170K
View Full List

About IMARA Inc.

IMRA Quotes by TradingView
  • Ticker IMRA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,287,300
  • Market Cap $552M
  • Description
  • IMARA Inc., a clinical-stage biopharmaceutical company, develops and commercializes therapeutics for patients with rare genetic disorders of hemoglobin. Its lead product candidate is IMR-687, an oral and once-a-day therapeutic that is in Phase 2b clinical trials for the treatment of sickle cell disease and ß-thalassemia. The company also develop...
More about IMRA
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email